Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2023 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
ELTX on Nasdaq
Shares outstanding
16,785,250
Price per share
$8.19
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,079,772
Total reported value
$16,555,641
% of total 13F portfolios
0%
Share change
+162,831
Value change
+$1,116,140
Number of holders
37
Price from insider filings
$8.19
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GKCC, LLC 48% $52,827,914 9,764,864 Yekaterina Chudnovsky 03 Jun 2025
Chudnovsky Yekaterina 48% $49,543,175 9,657,539 Yekaterina Chudnovsky 05 Mar 2025
Knoll Capital Management, LLC 5.2% $3,236,594 630,915 Knoll Capital Management, LLC 30 Jan 2025
Actyus Private Equity SGIIC, S.A. 1.6% -76% $3,142,199 -$6,877,471 268,564 -69% Actyus Private Equity SGIIC, S.A. 30 Sep 2025

As of 31 Dec 2025, 37 institutional investors reported holding 2,079,772 shares of Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX). This represents 12% of the company’s total 16,785,250 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Knoll Capital Management, LLC 3.8% 630,915 0% 2.3% $5,022,083
VANGUARD GROUP INC 3% 496,901 +4.9% 0% $3,955,331
Balyasny Asset Management L.P. 0.83% 138,762 -6.3% 0% $1,104,546
GEODE CAPITAL MANAGEMENT, LLC 0.79% 132,518 +2.2% 0% $1,055,243
MARSHALL WACE, LLP 0.7% 117,200 +35% 0% $932,911
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.38% 64,052 -47% 0% $509,854
683 Capital Management, LLC 0.34% 56,442 0.04% $449,278
NORTHERN TRUST CORP 0.31% 52,769 -1.5% 0% $420,041
STATE STREET CORP 0.28% 46,300 +21% 0% $368,548
BlackRock, Inc. 0.27% 45,179 +2.2% 0% $359,625
UBS Group AG 0.19% 32,016 +356% 0% $254,847
RENAISSANCE TECHNOLOGIES LLC 0.17% 28,111 -42% 0% $223,764
CM Management, LLC 0.15% 25,000 +317% 0.17% $199,000
OMERS ADMINISTRATION Corp 0.14% 23,500 0% $187,060
Qube Research & Technologies Ltd 0.12% 20,216 0% $160,919
Quadrature Capital Ltd 0.1% 17,159 0% $136,586
Squarepoint Ops LLC 0.1% 16,662 0% $132,630
OCCUDO QUANTITATIVE STRATEGIES LP 0.09% 15,827 0.01% $125,983
MORGAN STANLEY 0.09% 14,553 +847% 0% $115,842
MEYER HANDELMAN CO 0.08% 13,899 0% 0% $110,636
Jefferies Financial Group Inc. 0.07% 11,942 +130% 0% $95,058
Point72 Asset Management, L.P. 0.07% 11,652 0% $92,750
HighTower Advisors, LLC 0.07% 11,186 0% $89,041
Summit Financial, LLC 0.06% 10,010 0% $79,680
&PARTNERS 0.06% 10,000 0% 0% $79,600

Institutional Holders of Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,079,772 $16,555,641 +$1,116,140 $7.96 37
2025 Q3 1,911,273 $20,875,759 +$5,121,932 $10.94 28
2025 Q2 1,450,816 $11,188,879 -$640,781 $7.72 21
2025 Q1 1,591,744 $9,804,572 +$7,009,113 $6.16 24
2024 Q4 454,072 $2,254,908 -$189,626 $5.10 17
2024 Q3 491,473 $2,479,497 -$395,067 $5.03 18
2024 Q2 648,667 $2,679,243 +$952,436 $4.11 19
2024 Q1 405,757 $3,073,195 +$531,181 $7.60 17
2023 Q4 332,813 $2,775,559 +$9,460 $8.34 17
2023 Q3 330,928 $2,796,450 +$381,643 $8.45 17
2023 Q2 285,765 $2,714,943 +$2,714,943 $9.50 15